MR 引导放疗中自主无监督计划的临床评估：前列腺癌。
Clinical evaluation of autonomous, unsupervised planning integrated in MR-guided radiotherapy for prostate cancer.
机构信息
Section for Biomedical Physic, Department of Radiation Oncology, University Hospital Tübingen, Germany.
Department of Radiation Oncology, University Hospital Tübingen, Germany.
出版信息
Radiother Oncol. 2022 Mar;168:229-233. doi: 10.1016/j.radonc.2022.01.036. Epub 2022 Feb 5.
This retrospective study aimed at clinical evaluation of autonomous radiotherapy planning for ten prostate cancer cases, including organ-at-risk/target contouring and treatment planning. Five experts scored the clinical acceptability of each step using a 4-level Likert-scale resulting in 78%, 66% and 90% acceptance. For 6/10 patients the entire workflow was considered acceptable.
本回顾性研究旨在对 10 例前列腺癌患者的自主放疗计划进行临床评估，包括危及器官/靶区勾画和治疗计划制定。5 名专家使用 4 级 Likert 量表对每个步骤的临床可接受性进行评分，结果分别为 78%、66%和 90%。在 6/10 例患者中，整个工作流程被认为是可接受的。
Zotero 插件